Bio Key International Return on Equity (ROE) Growth & History (BKYI)
Bio Key International's return on equity was −161.24% for fiscal 2025.
View full Bio Key International company overviewBio Key International annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −161.24% | +16.64 pp |
| 2024 | 2024-12-31 | −177.88% | +89.89 pp |
| 2023 | 2023-12-31 | −267.77% | −153.89 pp |
| 2022 | 2022-12-31 | −113.88% | −85.70 pp |
| 2021 | 2021-12-31 | −28.18% | +79.01 pp |
| 2020 | 2020-12-31 | −107.19% | +249.45 pp |
| 2019 | 2019-12-31 | −356.65% | −299.92 pp |
| 2018 | 2018-12-31 | −56.72% | −27.44 pp |
| 2017 | 2017-12-31 | −29.28% | −4.34 pp |
| 2016 | 2016-12-31 | −24.94% | −5.29 pp |
| 2015 | 2015-12-31 | −19.64% | +188.49 pp |
| 2014 | 2014-12-31 | −208.13% | — |
Bio Key International quarterly return on equity
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −12.50% | +3.73 pp |
| Q1 2026 | 2026-03-31 | −4.10% | +8.94 pp |
| Q4 2025 | 2025-12-31 | −76.92% | −6.01 pp |
| Q3 2025 | 2025-09-30 | −14.96% | — |
| Q2 2025 | 2025-06-30 | −16.24% | — |
| Q1 2025 | 2025-03-31 | −13.04% | +50.78 pp |
| Q4 2024 | 2024-12-31 | −70.91% | +799.52 pp |
| Q1 2024 | 2024-03-31 | −63.81% | −26.54 pp |
| Q4 2023 | 2023-12-31 | −870.43% | −788.14 pp |
| Q3 2023 | 2023-09-30 | −483.98% | −464.62 pp |
| Q2 2023 | 2023-06-30 | −99.16% | −87.30 pp |
| Q1 2023 | 2023-03-31 | −37.28% | −30.83 pp |
| Q4 2022 | 2022-12-31 | −82.29% | −70.05 pp |
| Q3 2022 | 2022-09-30 | −19.36% | −13.68 pp |
| Q2 2022 | 2022-06-30 | −11.85% | −5.76 pp |
| Q1 2022 | 2022-03-31 | −6.45% | −2.19 pp |
| Q4 2021 | 2021-12-31 | −12.24% | −5.40 pp |
| Q3 2021 | 2021-09-30 | −5.68% | +23.64 pp |
| Q2 2021 | 2021-06-30 | −6.09% | — |
| Q1 2021 | 2021-03-31 | −4.26% | — |
| Q4 2020 | 2020-12-31 | −6.84% | +387.44 pp |
| Q3 2020 | 2020-09-30 | −29.32% | −5.24 pp |
| Q4 2019 | 2019-12-31 | −394.28% | −381.88 pp |
| Q3 2019 | 2019-09-30 | −24.08% | −9.97 pp |
| Q2 2019 | 2019-06-30 | −16.52% | −2.76 pp |
| Q1 2019 | 2019-03-31 | −18.35% | −1.72 pp |
| Q4 2018 | 2018-12-31 | −12.40% | −15.92 pp |
| Q3 2018 | 2018-09-30 | −14.12% | −2.10 pp |
| Q2 2018 | 2018-06-30 | −13.75% | −0.70 pp |
| Q1 2018 | 2018-03-31 | −16.63% | −7.42 pp |
| Q4 2017 | 2017-12-31 | 3.52% | +7.00 pp |
| Q3 2017 | 2017-09-30 | −12.02% | −4.36 pp |
| Q2 2017 | 2017-06-30 | −13.06% | −4.55 pp |
| Q1 2017 | 2017-03-31 | −9.21% | −2.58 pp |
| Q4 2016 | 2016-12-31 | −3.48% | +3.31 pp |
| Q3 2016 | 2016-09-30 | −7.66% | +443.95 pp |
| Q2 2016 | 2016-06-30 | −8.51% | −213.99 pp |
| Q1 2016 | 2016-03-31 | −6.63% | +244.71 pp |
| Q4 2015 | 2015-12-31 | −6.79% | +197.52 pp |
| Q3 2015 | 2015-09-30 | −451.61% | — |
| Q2 2015 | 2015-06-30 | 205.49% | +620.15 pp |
| Q1 2015 | 2015-03-31 | −251.34% | −217.74 pp |
| Q4 2014 | 2014-12-31 | −204.31% | +1603.06 pp |
| Q2 2014 | 2014-06-30 | −414.67% | — |
| Q1 2014 | 2014-03-31 | −33.60% | — |
| Q4 2013 | 2013-12-31 | −1,807.37% | — |
| Q2 2011 | 2011-06-30 | −144.78% | — |
Bio Key International return on equity trends
Over the last five fiscal years, Bio Key International's return on equity decreased from −107.19% to −161.24%, a change of −54.04 percentage points. The latest reported quarter, Q2 2026, shows −12.50%.
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Bio Key International source filings ↗